The insider sales are too small to signal any material concern. Monitor upcoming quarterly earnings for any guidance revision or pipeline update, as the stock's recent weakness (-2.25% avg T+20 return on prior reports) suggests broader headwinds.
Price Chart
Executive Summary
Pacira BioSciences saw two insider sales totaling $372K over a week, including the Chief Administrative Officer and SVP of Finance. The total value is 0.04% of the $905M market cap, which is trivial. The cluster is dominated by non-cash director grants ($0 value) that carry no economic signal, making the selling activity routine and non-informative.
Key Financial Metrics
Key Facts
- Two insiders sold shares: CAO Kristen Williams ($228K) and SVP Finance Lauren Riker ($144K), total $372K.
- Total selling value is 0.04% of $905M market cap — trivial and routine.
- 14 director grants (non-cash, $0 value) occurred on 2026-06-10, representing standard equity compensation, not a trading signal.
- Historical calibration shows past PCRX reports had a 33% win rate at T+20 with -2.25% average return, suggesting the stock has been weak regardless of filing content.
Financial Impact
Insider sales of $372K represent 0.04% of market cap — immaterial.
Risk Factors
- No material insider buying to offset the selling pattern.
- Stock has underperformed SPY by -7.46% alpha at T+20 on prior reports, indicating persistent negative sentiment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PCRX-1781312904049 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 8w ago | Press Release | $25.58 $26.60 | ▲ +3.99% | ▲ +3.39% | $25.21 (−1.45%) |
Jul 22, 2026 10w ago | Press Release | $25.59 $24.36 | ▼ −4.81% | ▼ −7.70% | $25.21 (−1.48%) |
Jun 30, 2026 13w ago | 8-K | $25.37 $26.47 | ▲ +4.34% | ▲ +5.36% | $25.21 (−0.63%) |
Jun 13, 2026 15w ago | Insider Cluster | $22.74 $25.54 | ▲ +12.31% | ▲ +13.06% | $25.21 (+10.86%) |
Jun 4, 2026 17w ago | DEFA14A | $22.75 $25.59 | ▲ +12.48% | ▲ +10.62% | $25.21 (+10.81%) |
Jun 4, 2026 17w ago | 144 | $22.67 $25.39 | ▲ +12.00% | ▲ +13.37% | $25.21 (+11.20%) |
Jun 1, 2026 17w ago | DEFA14A | $22.25 $25.03 | ▲ +12.49% | ▲ +14.06% | $25.21 (+13.30%) |
May 27, 2026 18w ago | DEFA14A | $23.68 $25.24 | ▲ +6.59% | ▲ +9.73% | $25.21 (+6.46%) |
May 26, 2026 18w ago | DEFA14A | $24.04 $24.37 | ▲ +1.37% | ▲ +3.27% | $25.21 (+4.87%) |
May 20, 2026 19w ago | DEFA14A | $23.48 $22.72 | ▼ −3.24% | ▼ −3.57% | $25.21 (+7.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access